Back to search results

Transition Care for First Episode Psychosis

This study is looking at a new way to help people who have experienced a first episode of psychosis (FEP) – conditions like schizophrenia or bipolar disorder with psychotic features – move from hospital care to regular outpatient mental health services. Many people lose touch with care after leaving the hospital, which can make recovery harder. This study is testing a new program called the Transition Care Team (TCT). The TCT is a group of healthcare professionals who support patients both in the hospital and for a short time after they go home. They offer education, help with managing care, and connect patients with ongoing community programs. The main goal is to see if the TCT helps more patients successfully start outpatient treatment after their hospital stay. You might be able to join if you are 18-40 years old, speak English, and have been diagnosed with a psychotic disorder for less than two years. The study status is currently unclear.

Study design
This is an observational study with a planned enrollment of 75 participants. It is looking at the effectiveness of the Transition Care Team (TCT) intervention.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The effectiveness of the Transition Care Team is measured at 6 weeks post-discharge.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07713849

Transition Care for FEP

Recruiting
Not specifiedAges 18–40Observational
University of Chicago
~75 participants
Updated 2026-07-20 on ClinicalTrials.gov
What's tested:Transition Care Team

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Effectiveness of Transition Care Team for First Episode Psychosis
Measured over 6 weeks post-discharge

Conditions

Schizoaffective Disorders
Bipolar Disorder With Psychotic Features
Schizophrenia Disorders
Major Depressive Disorder With Psychotic Features
Psychosis NOS

Explore related trials

Bipolar DisorderFirst Episode PsychosisPsychosis NOSSchizoaffective DisorderSchizophreniaSchizophreniform DisorderUnipolar Depression

Where it's being run

2 sites across 1 states
Illinois2

Study leadership

  • Molly Erickson, PhD · PRINCIPAL_INVESTIGATOR · University of Chicago
  • Carolyn Shima, PhD · PRINCIPAL_INVESTIGATOR · University of Chicago
  • Sarah Keedy, PhD · PRINCIPAL_INVESTIGATOR · University of Chicago

Who to contact

Madeline Perez Lab Manager, B.S
[email protected]
773-712-9178
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder with psychotic features, major depressive disorder with psychotic features, schizophreniform disorder, or psychosis NOS
The diagnosis of one of the psychotic disorders has a duration of less than two years.
Able to read, speak, and understand English, which will be assessed through observation.
Able and willing to provide written informed consent or assent, in cases where caregivers are considered legal guardians. Dr. Shima, co-I of the study, is a forensic psychiatrist, and particularly adept at judging such ability. Drs. Erickson and Keedy have conducted studies in individuals with psychotic disorders, including FEP and in the context of clinical trials, for years, and are similarly competent to judge whether individuals can provide informed consent. Finally, we will also use an Evaluation to Sign Consent form that documents subjects' verbalized understanding of key aspects of the study.
have an estimated IQ of \> 65, assessed by the Wechsler Test of Adult Reading
Eligible caregivers/proxy informants must be identified by the participant or clinical team as being involved in the participant's discharge planning or follow-up care, be able to provide informed verbal consent, and be able to speak and read English sufficiently to complete study questionnaires. Caregivers may include family members, close supports, or legally authorized representatives.

Exclusion

Individuals with substance-induced psychosis or psychosis due to a medical condition will not be included in the study. We will use the Structured Clinical Interview for DSM-5 as well as medical records, and if the subject gives permission, caregiver information in this process
Individuals who do not meet criteria for a first episode of psychosis

What this trial measures

  • Effectiveness of Transition Care Team for First Episode Psychosis6 weeks post-discharge

    Attendance at 1 or more than 1 CSC appointment within 6 weeks of discharge